Strategic Asset Leasing, Inc. – OTC:LEAS

Strategic Asset Leasing stock price today

$0.004
+0.00
+1300%
Financial Health
0
1
2
3
4
5
6
7
8
9

Strategic Asset Leasing stock price monthly change

-100.00%
month

Strategic Asset Leasing stock price quarterly change

-100.00%
quarter

Strategic Asset Leasing stock price yearly change

-100.00%
year

Strategic Asset Leasing key metrics

Market Cap
 1.16M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 -652.37K
Income
 -684.86K
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Strategic Asset Leasing stock price history

Strategic Asset Leasing stock forecast

Strategic Asset Leasing financial statements

Profit Margin

Strategic Asset Leasing, Inc. (OTC:LEAS): Profit margin
Dec 2022 0 -103.88K
Mar 2023 0 -172.48K
Jun 2023 0 -264.38K
Sep 2023 0 -144.11K
LEAS income statement history

Debt to Assets

Strategic Asset Leasing, Inc. (OTC:LEAS): Debt to assets
Sep 2023 2293656 1.59M 69.56%
LEAS balance sheet history

Cash Flow

Strategic Asset Leasing, Inc. (OTC:LEAS): Cash Flow
Dec 2022 -103.44K -49.76K -250K
Mar 2023 -161.90K -10K 250K
Jun 2023 -103.52K -10K 125
Sep 2023 -81.97K -56.32K 100K
LEAS cash flow history

Strategic Asset Leasing alternative data

Strategic Asset Leasing
Employees

Strategic Asset Leasing, Inc. (OTC:LEAS): Employee count
Aug 2023 3
Sep 2023 3
Oct 2023 3
Nov 2023 1
Dec 2023 1
Jan 2024 1
Feb 2024 1
Mar 2024 1
May 2024 1
Jun 2024 1
Jul 2024 1

Strategic Asset Leasing other data

Frequently Asked Questions (FAQ)

  • What's the price of Strategic Asset Leasing stock today?

    One share of Strategic Asset Leasing stock can currently be purchased for approximately $0.

  • When is Strategic Asset Leasing's next earnings date?

    Unfortunately, Strategic Asset Leasing's (LEAS) next earnings date is currently unknown.

  • Does Strategic Asset Leasing pay dividends?

    No, Strategic Asset Leasing does not pay dividends.

  • How much money does Strategic Asset Leasing make?

    Strategic Asset Leasing has a market capitalization of 1.16M.

  • What is Strategic Asset Leasing's stock symbol?

    Strategic Asset Leasing, Inc. is traded on the OTC under the ticker symbol "LEAS".

  • What is Strategic Asset Leasing's primary industry?

    Company operates in the Industrials sector and Rental & Leasing Services industry.

  • How do i buy shares of Strategic Asset Leasing?

    Shares of Strategic Asset Leasing can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Strategic Asset Leasing have?

    As Jul 2024, Strategic Asset Leasing employs 1 workers.

  • When Strategic Asset Leasing went public?

    Strategic Asset Leasing, Inc. is publicly traded company for more then 25 years since IPO on 4 Jan 2000.

  • What is Strategic Asset Leasing's official website?

    The official website for Strategic Asset Leasing is anewmeds.com.

  • Where are Strategic Asset Leasing's headquarters?

    Strategic Asset Leasing is headquartered at 545 Eighth Avenue, New York, NY.

  • How can i contact Strategic Asset Leasing?

    Strategic Asset Leasing's mailing address is 545 Eighth Avenue, New York, NY and company can be reached via phone at +212 6135453.

Strategic Asset Leasing company profile:

Strategic Asset Leasing, Inc.

anewmeds.com
Exchange:

OTC

Full time employees:

3

Industry:

Rental & Leasing Services

Sector:

Industrials

Anew Medical, Inc. focuses on developing biologic medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. The company is based in Omaha, Nebraska.

+212 6135453
545 Eighth Avenue
New York, NY 68144

:
ISIN: US86270P1066
CUSIP: 86270P106